Nutex Health Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Nutex Health Inc. on July 5, 2024, covering events occurring on July 1, 2024. The filing details the implementation of a reverse stock split previously authorized by stockholders at the annual meeting on June 17, 2024.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and capital structure adjustments.
Material Changes
- Reverse Stock Split Execution: The Company filed a Certificate of Amendment with the Delaware Secretary of State on July 1, 2024, to effect a 1-for-10 reverse stock split.
- Effective Date: The split became effective at 11:59 p.m. Eastern Time on July 2, 2024.
- Share Consolidation: Every 10 shares of issued and outstanding common stock were automatically combined into one share. No fractional shares were issued; holders received one whole share for fractional interests.
- Trading Resumption: Common stock began trading on a post-split basis on the Nasdaq Stock Market under the symbol "NUTX" on July 3, 2024.
- Identification Update: The new CUSIP number for the common stock is 67079U306.
- Equity Adjustments: Proportionate adjustments were made to exercise prices and share counts for outstanding equity awards and incentive plans.
- Authorized Shares: The total number of authorized shares remains at 950,000,000.
Guidance, Outlook, and Risks
The filing does not provide forward-looking guidance, management commentary on financial outlook, or specific risk factors beyond the standard mechanics of the stock split. The Company noted that this 1-for-10 split is in addition to a previous 1-for-15 reverse stock split effective April 10, 2024.
Investor Verification Checklist
- Verify the new CUSIP number (67079U306) with your broker to ensure proper account adjustment.
- Confirm that your brokerage account reflects the 1-for-10 consolidation of share positions.
- Review the impact of the split on the exercise price and number of shares for any outstanding stock options or awards.
- Note that the stock resumed trading on July 3, 2024, under the existing symbol "NUTX."